Cti Biopharm Corp
(CTIC)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
| 12-2017 | 12-2016 | 12-2015 | 12-2014 | 12-2013 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -40,831 | -52,953 | -120,763 | -94,229 | -43,550 |
| Depreciation Amortization | 717 | 831 | 990 | 1,100 | 1,570 |
| Accounts receivable | 402 | -156 | 1,555 | -1,980 | -227 |
| Accounts payable and accrued liabilities | -4,730 | -3,025 | 4,368 | 1,454 | -5,774 |
| Other Working Capital | -6,172 | -8,576 | 7,456 | 9,683 | -3,794 |
| Other Operating Activity | 11,318 | -12,801 | 11,191 | 44,422 | 15,945 |
| Operating Cash Flow | $-39,296 | $-76,680 | $-95,203 | $-39,550 | $-35,830 |
| Cash Flows From Investing Activities | |||||
| Change In Deposits | 11 | N/A | N/A | N/A | N/A |
| PPE Investments | -49 | -137 | -78 | -333 | -1,534 |
| Other Investing Activity | 0 | 0 | 0 | -208 | 0 |
| Investing Cash Flow | $-38 | $-137 | $-78 | $-541 | $-1,534 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | 15,971 | N/A | 10,820 | 4,963 | 14,501 |
| Debt Repayment | -19,548 | -5,452 | -4,659 | -1,526 | N/A |
| Common Stock Issued | 10 | N/A | 15,147 | N/A | N/A |
| Other Financing Activity | 42,546 | -1,914 | 130,709 | 32,589 | 44,471 |
| Financing Cash Flow | $38,979 | $-7,366 | $152,017 | $36,026 | $58,972 |
| Exchange Rate Effect | -429 | 3 | 513 | 3,359 | -405 |
| Beginning Cash Position | 44,002 | 128,182 | 70,933 | 71,639 | 50,436 |
| End Cash Position | 43,218 | 44,002 | 128,182 | 70,933 | 71,639 |
| Net Cash Flow | $-784 | $-84,180 | $57,249 | $-706 | $21,203 |
| Free Cash Flow | |||||
| Operating Cash Flow | -39,296 | -76,680 | -95,203 | -39,550 | -35,830 |
| Capital Expenditure | -49 | -137 | -78 | -333 | -1,657 |
| Free Cash Flow | -39,345 | -76,817 | -95,281 | -39,883 | -37,487 |